1. Home
  2. SPRC vs XYLO Comparison

SPRC vs XYLO Comparison

Compare SPRC & XYLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • XYLO
  • Stock Information
  • Founded
  • SPRC 2004
  • XYLO 1999
  • Country
  • SPRC Israel
  • XYLO Israel
  • Employees
  • SPRC N/A
  • XYLO N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • XYLO
  • Sector
  • SPRC Health Care
  • XYLO
  • Exchange
  • SPRC Nasdaq
  • XYLO NYSE
  • Market Cap
  • SPRC 2.3M
  • XYLO 2.2M
  • IPO Year
  • SPRC N/A
  • XYLO N/A
  • Fundamental
  • Price
  • SPRC $0.23
  • XYLO $2.92
  • Analyst Decision
  • SPRC
  • XYLO
  • Analyst Count
  • SPRC 0
  • XYLO 0
  • Target Price
  • SPRC N/A
  • XYLO N/A
  • AVG Volume (30 Days)
  • SPRC 793.5K
  • XYLO 21.9K
  • Earning Date
  • SPRC 11-26-2024
  • XYLO 11-29-2024
  • Dividend Yield
  • SPRC N/A
  • XYLO N/A
  • EPS Growth
  • SPRC N/A
  • XYLO N/A
  • EPS
  • SPRC N/A
  • XYLO N/A
  • Revenue
  • SPRC $1,747,000.00
  • XYLO $57,642,000.00
  • Revenue This Year
  • SPRC N/A
  • XYLO N/A
  • Revenue Next Year
  • SPRC N/A
  • XYLO N/A
  • P/E Ratio
  • SPRC N/A
  • XYLO N/A
  • Revenue Growth
  • SPRC N/A
  • XYLO N/A
  • 52 Week Low
  • SPRC $0.21
  • XYLO $2.70
  • 52 Week High
  • SPRC $14.22
  • XYLO $10.43
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 44.04
  • XYLO 41.43
  • Support Level
  • SPRC $0.22
  • XYLO $2.71
  • Resistance Level
  • SPRC $0.25
  • XYLO $3.13
  • Average True Range (ATR)
  • SPRC 0.02
  • XYLO 0.33
  • MACD
  • SPRC 0.00
  • XYLO -0.06
  • Stochastic Oscillator
  • SPRC 35.68
  • XYLO 16.56

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About XYLO XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.

Share on Social Networks: